Overview
BioIVT is a leading global provider of research models and value-added research services for drug discovery and development. We specialize in control and disease-state biospecimens including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. And as the premier supplier of hepatic products, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and their effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in elevating science. For more information, please visit www.bioivt.com or follow the company on Twitter @BioIVT.
Company News
BioIVT Expands its Biospecimen Portfolio in Support of Neuroscience Research
Oct 27, 2023
Posted by BioIVT
BioIVT Elevates Cell and Gene Therapy to an Artform at Meeting on the Mesa
Oct 03, 2023
Posted by BioIVT
Company Events
Trending Topics in ADME & Drug Development Research: Novel Methodologies to Improve IVIVC
Nov 06, 2024
MassBioHub